HCP
56
2
EQIX
59
2
PFE
33
-2
DD
45
4
PPG
60
3
AME
50
3
TXN
35
5
T
36
4
PNC
49
3
ISRG
70
4
SYK
57
6
NFLX
74
4
AVB
55
3
MCO
73
5
KMX
58
6
CAH
47
2
MNST
52
6
SE
60
3
SBUX
36
5
PX
58
5
HCP
56
2
EQIX
59
2
PFE
33
-2
DD
45
4
PPG
60
3
AME
50
3
TXN
35
5
T
36
4
PNC
49
3
ISRG
70
4
SYK
57
6
NFLX
74
4
AVB
55
3
MCO
73
5
KMX
58
6
CAH
47
2
MNST
52
6
SE
60
3
SBUX
36
5
PX
58
5
Financhill
Back

Akero Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
28

AKRO
Akero Therapeutics

Last Price:
$28.82
Seasonality Move:
-9.11%
Sell
35

NBY
NovaBay Pharmaceuticals

Last Price:
$0.56
Seasonality Move:
-0.66%
Sell
28
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $28.56. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.54. The Score for NBY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $28.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 42.92 Sell
Chaikin Money Flow: 107245 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.15 - 31.69) Sell
Bollinger Bands (100): (26.14 - 31.32) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.52 Sell
Chaikin Money Flow: 22882 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.65) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.02 Sell
20-day SMA: 30.16 Sell
50-day SMA: 30.77 Sell
200-day SMA: 25.89 Buy
8-day EMA: 29.06 Sell
20-day EMA: 29.8 Sell
50-day EMA: 29.96 Sell
200-day EMA: 27.84 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.53 Buy
20-day SMA: 0.56 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.84 Sell
8-day EMA: 0.53 Buy
20-day EMA: 0.57 Sell
50-day EMA: 0.63 Sell
200-day EMA: 4.62 Sell

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):